Crohn's disease - The Lancet
4.7 (472) · $ 9.00 · In stock
Prognostic biomarkers for pediatric Crohn's disease - Olink
Crohn's disease and EEN
Mechanisms in failure of infliximab for Crohn's disease - The Lancet
Maintenance of remission in Crohn's disease - NICE Guidelines 2019
Pathophysiology of Crohn's Disease - 1407 Words
Azathioprine in the Treatment of Crohn's Disease - J E Lennard
Rob Brierley on LinkedIn: #ibd #machinelearning #gastroenterology #hepatology #oncology…
Associated Conditions
Crohn's disease - The Lancet
Laparoscopic ileocaecal resection versus infliximab for terminal ileitis in Crohn's disease: retrospective long-term follow-up of the LIR!C trial - The Lancet Gastroenterology & Hepatology
Frontiers An Update for Pharmacologists on New Treatment Options for Inflammatory Bowel Disease: The Clinicians' Perspective
Gastrointestinal Disorders, Free Full-Text
What's the Difference Between IBS and Different Types of IBD? - GoodRx
PDF] Crohn's disease
